Author:
Varma Kachnar,Hille Jos,Afrogheh Amir,Mehrotra Ravi
Reference26 articles.
1. Peacock ZS, Pogrel A, Schmidt BL. Exploring the reasons for delay in treatment of oral cancer. J Am Dent Assoc. 2008;139:1346–52.
2. Sankaranarayanan R, Ramadas K, Thomas G, et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005;365:1927–33.
3. Trullenque-Eriksson A, Muñoz-Corcuera M, Campo-Trapero J, Cano-Sánchez J, Bascones-Martínez A. Analysis of new diagnostic methods in suspicious lesions of the oral mucosa. Med Oral Patol Oral Cir Bucal. 2009;14:210–6.
4. Epstein JB, Sciubba J, Silverman Jr S, Sroussi HY. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice. Head Neck. 2007;29:948–58.
5. Hopper C, Kalavrezos N. Oral cytology: the surgical perspective. Cytopathology. 2007;18:329–30.